An investigation of why eligible patients do not receive HAART

AIDS Patient Care and STDs

Volumn 15, Issue 4, 2001, Pages 185-191

  Maisels, L ^a   Steinberg, J ^b   Tobias, C ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b East Boston Neighborhood Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONFIDENTIALITY; DEPRESSION; HEALTH CARE COST; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; SUBSTANCE ABUSE;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BOSTON; COMMUNITY HEALTH CENTERS; HIV INFECTIONS; HUMANS; MEDICAL RECORDS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TREATMENT REFUSAL; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 0035041225     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910151133701     Document Type: Article

References (10)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Modeling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy
3. AIDS researchers target poor adherence
4. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States
5. Delays in protease inhibitor use in clinical practice
6. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility
7. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?
8. HIV-infected women's decisions to take antiretrovirals
9. When should we delay highly active anti-retroviral therapy
10. Rethinking adherence: Historical perspectives on triple-drug therapy for HIV disease